TWA
SRNE

TCI Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

TCI Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,990
Closed -$5K – 2701
2022
Q3 		$5K Buy
2,990
+393
+15% +$891 ﹤0.01% 1547
2022
Q2 		$5K Buy
2,597
+401
+18% +$693 ﹤0.01% 1569
2022
Q1 		$5K Buy
2,196
+1,039
+90% +$3.24K ﹤0.01% 1640
2021
Q4 		$5K Buy
1,157
+657
+131% +$4.08K ﹤0.01% 1756
2021
Q3 		$4K Sell
500
-297
-37% -$2.52K ﹤0.01% 1865
2021
Q2 		$8K Sell
797
-9
-1% -$72 ﹤0.01% 1158
2021
Q1 		$7K Buy
806
+213
+36% +$2.25K ﹤0.01% 1102
2020
Q4 		$4K Hold
593
– – ﹤0.01% 1041
2020
Q3 		$7K Hold
593
– – ﹤0.01% 692
2020
Q2 		$4K Buy
+593
New +$2.27K ﹤0.01% 854
2019
Q4 		– Sell
-300
Closed -$1K – 1720
2019
Q3 		$1K Sell
300
-200
-40% -$466 ﹤0.01% 1434
2019
Q2 		$1K Buy
500
+200
+67% +$720 ﹤0.01% 1359
2019
Q1 		$1K Buy
300
+100
+50% +$262 ﹤0.01% 1351
2018
Q4 		$0 Sell
200
-100
-33% -$327 ﹤0.01% 1724
2018
Q3 		$1K Sell
300
-200
-40% -$1.11K ﹤0.01% 1392
2018
Q2 		$4K Buy
500
+300
+150% +$2.04K ﹤0.01% 891
2018
Q1 		$1K Buy
+200
New +$1.42K ﹤0.01% 1270

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TCI Wealth Advisors's SRNE Position: Q4 2022 in Review

TCI Wealth Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 2,990 shares — an estimated $5K sold.

TCI Wealth Advisors first reported a position in SRNE in Q1 2018 and held it in 17 quarters. The position peaked at $8K in Q2 2021. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

  • TCI Wealth Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 2,990 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $5K.
  • TCI Wealth Advisors first reported a position in Sorrento Therapeutics, Inc. in Q1 2018 and held it in 17 quarters.
  • TCI Wealth Advisors's Sorrento Therapeutics, Inc. position peaked at $8K in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.